Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MDMA/assisted therapy
Recent news which mentions MDMA/assisted therapy
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
March 26, 2024
Tickers
MDXXF
NEWS
NUMIF
OPTHF
Tags
News
Management
Tel Aviv University
From
Benzinga
Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
January 04, 2024
Tickers
ATAI
NEWS
Tags
Benzinga
MDMA/assisted therapy
Psychedelic/Assisted Therapies
From
Benzinga
Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application
December 12, 2023
Tags
Legal
Government
News
From
Benzinga
Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program
September 25, 2023
Tags
News
Psychedelics
Management
From
Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
Tags
Psychedelics
Rumors
Global
From
Benzinga
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next
September 14, 2023
Tags
Psychedelics
News
Psychedelics Reform
From
Benzinga
Fluence Inks Deal To Bring Brazil's Psychedelic Therapy Training Scene To New Heights
July 26, 2023
Tags
Phaneros Institute
Psychedelics
Contracts
From
Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
Tickers
NUMIF
OPTHF
PMBHF
Tags
Psychedelic/Assisted Therapies
MDMA/assisted therapy
NUMIF
From
Benzinga
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study
June 16, 2023
Tickers
MAPS
NUMIF
Tags
General
Government
Canada
From
Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
Tags
Markets
Guidance
Schizophrenia
From
Benzinga
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
June 09, 2023
Tickers
COPHF
MNMD
Tags
News
MNMD
Markets
From
Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
April 19, 2023
Tickers
AWKNF
Tags
George McBride
Cannabis
Nick Kadysh
From
Benzinga
Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
April 11, 2023
Tickers
FLHLF
Tags
News
GMP Certification
Management
From
Benzinga
MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
April 03, 2023
Tickers
PHRRF
RVVTF
Tags
News
Markets
RVVTF
From
Benzinga
MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production
March 02, 2023
Tickers
AWKNF
Tags
News
Supply Chain
Controlled Substances Act
From
Benzinga
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
February 07, 2023
Tickers
NUMIF
Tags
News
Legal
Psilocybin/Assisted Therapy
From
Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
February 06, 2023
Tickers
IWINF
ORIG
PHRRF
PSIL
Tags
Markets
Canada Psychedelics
News
From
Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
February 06, 2023
Tickers
OPTHF
PHRRF
RVVTF
Tags
Cannabis
PHRRF
Psychedelics Investing
From
Benzinga
MDMA Therapy For Chronic PTSD: Neuroimaging With Veterans & First Responders Provides Further Evidence
January 23, 2023
Tags
PTSD
Benzinga
Veterans
From
Benzinga
Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More
January 10, 2023
Tickers
PSIL
PSYK
TRYPF
Tags
Global
TRYPF
Benzinga
From
Benzinga
Is Psychedelic Treatment Around The Corner? MDMA For PTSD Checks Positive In MAPS' 2nd Phase 3 Trial
January 05, 2023
Tags
News
MAPS PBC
Legal
From
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Tickers
AGNPF
BMNDF
CMND
CMPS
Tags
KONEF
MYCOF
BMNDF
From
Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
November 17, 2022
Tags
Markets
Legal
MAPS PBC
From
Benzinga
Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage
September 27, 2022
Tickers
ATAI
Tags
Small Cap
EmpathBio
Psychedelics
From
Benzinga
Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year
September 17, 2022
Tickers
AWKNF
Tags
Guidance
Markets
Earnings
From
Benzinga
Canadian Psychedelics Company Reduces Manufacturing Time Of MDMA By Two Thirds
September 07, 2022
Tags
Cannabis
Markets
Robert August
From
Benzinga
Canada: MDMA-Assisted Therapy Trials Reviewed By Health Canada, Here's What's Happening
July 25, 2022
Tickers
MAPS
Tags
Psychedelics
Health Canada
Benzinga
From
Benzinga
Missouri Patients With Life-Threatening Illnesses Can Seek Psychedelic Treatments Under 'Right To Try' Law
January 13, 2022
Tags
LSD
Politics
Markets
From
Benzinga
Australian Psychiatrist Sues State Of Victoria For Denying MDMA Treatment For Ailing Patient
November 17, 2021
Tags
Cannabis
Market News
FDA
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.